Tag: Aptorum
Aptorum Group Announces Clinical Validation Update of its Liquid Biopsy Infectious Disease Detection RPIDD Technology
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-phase biopharmaceutical company focused on innovative technologies for the treatment and diagnosis of infectious diseases, announces that…